|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
價值評估 |
盈利(現時/預測)
-13.22/-5.77
|
企業價值
4.11M
|
資產負債 |
每股賬面淨值
-2.86
|
現金流量 |
現金流量率
--
|
損益表 |
收益
0
|
每股收益
--
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘:2024/12/24 12:30 EST
同行比較之報價最少15分鐘延遲
業務概覽
|
|||
Silexion Therapeutics Corp is a developmental-stage company dedicated to the development of treatments for pancreatic cancer. The company is focused on enhancing its first-generation product (LODERTM ) to develop a newly formulated productto improve the clinical efficacy against pancreatic cancer. |